Patheon Inc: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial ReportiCD ResearchFebruary 4, 2012 33 Pages - SKU: ICDR6792312 |
| Synopsis ICD Research's Patheon Inc: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report contains in depth information and data about the company and its operations. The profile contains a company overview, business description, SWOT analysis, key facts, information on products and services, details of locations and subsidiaries, plus information on key news events affecting the company. Summary ICD Research's Patheon Inc: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report is a crucial resource for industry executives and anyone looking to access key information about Patheon Inc.. ICD Research's Patheon Inc: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report. Scope
Patheon Inc. (Patheon) is one of the leading drug manufacturers in Canada. The company principally focuses on discovery of new drugs, dosage form development, commercial manufacturing and packaging. Additionally, the company commercializes and distributes the drugs. The company offers a diverse range of services such as pre-formulation, analytical development, formulation development and clinical trial manufacturing. The company has its operations in various regions including Europe, and Canada. The company operates through its nine manufacturing facilities and eight development centers located in North America and Europe. The company serves more than 300 companies across the world. Patheon Inc. is headquartered in North Carolina, the US. |
Related Markets
Pharmaceuticals Company Reports
- Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q1 2012
- Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics
- Royalty Financing Terms and Agreements in Pharma, Biotech and Diagnostics
- Partnerships, Licensing, Investments and M&A Deals and Trends for March 2012 in Pharmaceuticals
- Contract Research Organizations (CROs) Market to 2018 - Public-Private Partnerships to Strengthen Research Capacities and Advance Clinical Development Programs

